Cancer News and Research

Latest Cancer News and Research

Rexahn receives approval to initiate RX-3117 Phase I trial in solid tumors

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing oncology and CNS therapeutics, today announced that it has secured Hungarian Regulatory Authority and Ethics Committee approval for Rexahn's initial Clinical Trial Application.

19 Jan 2012

First study to examine years of life lost in Brisbane climate change

Queensland University of Technology (QUT), in collaboration with CSIRO, has conducted a world-first study into the potential impact climate change will have on 'years of life lost' in Brisbane.

19 Jan 2012

Soligenix reports results from long-term stability studies of SGX204 anthrax vaccine

Soligenix, Inc., a development stage biopharmaceutical company, announced today results from long-term stability studies of its proprietary DNI anthrax rPA subunit protein vaccine, known as SGX204.

19 Jan 2012

Novel technique accurately maps gene-regulation proteins

A novel technique has been developed and demonstrated at Penn State University to map the proteins that read and regulate chromosomes -- the string-like structures inside cells that carry genes.

19 Jan 2012

GSA honors researchers, educators for distinguished service in the field of genetics

The Genetics Society of America (GSA) is pleased to announce the 2012 recipients of its five awards for distinguished service in the field of genetics. The recipients of these awards were nominated and selected by their colleagues.

19 Jan 2012

Scientists crack genetic code for Schistosoma haematobium

Scientists have cracked the genetic code and predicted some high priority drug targets for the blood parasite Schistosoma haematobium, which is linked to bladder cancer and HIV/ AIDS and causes the insidious urogenital disease schistosomiasis haematobia in more than 112 million people in Africa.

19 Jan 2012

Book outlines digital future of medicine

The inventions of cell phones, personal computers, and the Internet ushered in the digital revolution and altered our existence in ways that were unimaginable just a few decades ago. But the most precious part of our existence-our health-has so far been largely unaffected and insulated from these innovations.

19 Jan 2012

LabCorp announces nationwide availability of Risk of Ovarian Malignancy Algorithm

Laboratory Corporation of America Holdings announced today the nationwide availability of a new FDA cleared risk stratification tool (ROMA, Risk of Ovarian Malignancy Algorithm) that combines the results for Fujirebio HE4, Abbott's ARCHITECT CA 125 II, and menopausal status into a numerical score that, along with clinical and radiological evaluation, can aid in evaluating whether a woman over the age of 18 who presents with an ovarian mass and for whom surgery is planned is at high or low likelihood of finding malignancy on surgery.

19 Jan 2012

Live interactive consultations can improve clinical outcomes for patients

UC Davis Health System dermatologists, using videoconferencing technology known as teledemedicine, have determined that live interactive consultations can improve clinical outcomes for patients because they usually involve beneficial changes in medical diagnosis and disease management that otherwise might not occur.

19 Jan 2012

Bristol-Myers Squibb agrees purchase of Inhibitex for $2.5Bn

American pharmaceutical giant Bristol-Myers Squibb has agreed the purchase of US biotech company Inhibitex, in a $2.5Bn (£1.6bn) deal which includes the promising new anti-hepatitis C drug INX-189, first designed and prepared in Cardiff University.

19 Jan 2012

USPTO issues new patent to PBL's RNAi technology

Plant Bioscience Limited (PBL) is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued out US Patent No. 8,097,710 with fundamental claims directed to methods of inducing gene silencing using short RNA molecules, or DNA constructs encoding short RNA molecules, in a wide range of organisms, including in plants and humans.

19 Jan 2012

TB associated with EGFR mutations in patients with lung adenocarcinoma

Tuberculosis (TB) has been suspected to increase a person's risk of lung cancer because the pulmonary inflammation and fibrosis can induce genetic damage. However, direct evidence of specific genetic changes and the disease have not been extensively reported.

19 Jan 2012

EMA grants Orphan Drug Designation to Ceptaris' chlormethine gel for treatment of CTCL

Ceptaris Therapeutics, Inc., a privately held specialty pharmaceutical company, announced today that the European Medicines Agency (EMA) has granted Orphan Drug Designation to Ceptaris' investigational drug, chlormethine gel, for the treatment of Cutaneous T-Cell Lymphoma.

18 Jan 2012

State roundup: Single-payer plans in Calif., Vt.; Calif. may regain state prison health care control; Abortion issues in Texas, Minn.

The California universal health care bill didn't make it past the Senate Appropriations Committee last year -- but Tuesday, more than 100 advocates plan to present it to the committee again, hoping for a better outcome. Under the single-payer bill, Californians would pay the state -- instead of private insurance companies -- to negotiate health care. The bill would cover any resident, including the estimated 7 million Californians who don't have health insurance now. ... A legislative health committee estimated the cost of plan would be around $200 billion.

18 Jan 2012

HRT and breast cancer – the link questioned as study flaws are reported

There is a renewed doubt over the link between hormone replacement therapy and breast cancer after researchers cast aspersions over its justification.

18 Jan 2012

Melanoma drug makes pre-existing cells with RAS mutation grow into skin squamous cell cancers

Patients with metastatic melanoma taking the recently approved drug vemurafenib (Zelboraf) responded well to the twice daily pill, but some of them developed a different, secondary skin cancer.

18 Jan 2012

US faces shortage of donated blood

A person is in need of a blood donation every two seconds in the United States, according to statistics from America's Blood Centers, a network of non-profit community blood centers across the country. Because there is no known substitute for human blood, and it cannot be artificially manufactured, the entire process relies on generous donations from people willing to give. Unfortunately, there is currently a shortage of donated blood across the country.

18 Jan 2012

Researchers identify critical cellular, molecular events that lead to esophageal adenocarcinoma

Researchers at Columbia University Medical Center (CUMC) have identified the critical early cellular and molecular events that give rise to a type of esophageal cancer called esophageal adenocarcinoma, the fastest-rising solid tumor in the United States.

18 Jan 2012

Scientists identify pathway that activates hepsin on the surface of breast tumor cells

Scientists from the University of Helsinki and from UCSF have exposed a cell pathway that breast tumor cells use to destruct local tissue neighborhood. Cancer cells may use this pathway to free themselves from mammary epithelial tissue architecture, to spread to surrounding tissues. The cell pathway, the researchers found, is a biochemical chain of events leading to activation of a protein-cleaving enzyme on the surface of the tumor cells.

18 Jan 2012

Researchers to anticipate and track risk for infectious disease outbreak at London Olympics

A research team led by St. Michael's Hospital's Dr. Kamran Khan is teaming up with British authorities to anticipate and track the risk for an infectious disease outbreak at the London Olympics this summer.

18 Jan 2012

Cancer News and Research

Latest Cancer News and Research

Rexahn receives approval to initiate RX-3117 Phase I trial in solid tumors

First study to examine years of life lost in Brisbane climate change

Soligenix reports results from long-term stability studies of SGX204 anthrax vaccine

Novel technique accurately maps gene-regulation proteins

GSA honors researchers, educators for distinguished service in the field of genetics

Scientists crack genetic code for Schistosoma haematobium

Book outlines digital future of medicine

LabCorp announces nationwide availability of Risk of Ovarian Malignancy Algorithm

Live interactive consultations can improve clinical outcomes for patients

Bristol-Myers Squibb agrees purchase of Inhibitex for $2.5Bn

USPTO issues new patent to PBL's RNAi technology

TB associated with EGFR mutations in patients with lung adenocarcinoma

EMA grants Orphan Drug Designation to Ceptaris' chlormethine gel for treatment of CTCL

State roundup: Single-payer plans in Calif., Vt.; Calif. may regain state prison health care control; Abortion issues in Texas, Minn.

HRT and breast cancer – the link questioned as study flaws are reported

Melanoma drug makes pre-existing cells with RAS mutation grow into skin squamous cell cancers

US faces shortage of donated blood

Researchers identify critical cellular, molecular events that lead to esophageal adenocarcinoma

Scientists identify pathway that activates hepsin on the surface of breast tumor cells

Researchers to anticipate and track risk for infectious disease outbreak at London Olympics

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in